216 related articles for article (PubMed ID: 29680825)
1. Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities.
Polgreen LA; Riedle BN; Cavanaugh JE; Girotra S; London B; Schroeder MC; Polgreen PM
J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680825
[TBL] [Abstract][Full Text] [Related]
2. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
[TBL] [Abstract][Full Text] [Related]
3. Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.
Cornett E; Novitch MB; Kaye AD; Pann CA; Bangalore HS; Allred G; Bral M; Jhita PK; Kaye AM
Postgrad Med; 2017 Sep; 129(7):715-724. PubMed ID: 28770640
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions.
Bonaldo G; Andriani LA; D'Annibali O; Motola D; Vaccheri A
Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1457-1463. PubMed ID: 31423694
[TBL] [Abstract][Full Text] [Related]
5. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
Postma DF; Spitoni C; van Werkhoven CH; van Elden LJR; Oosterheert JJ; Bonten MJM
BMC Infect Dis; 2019 Jan; 19(1):17. PubMed ID: 30612559
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides.
Gorelik E; Masarwa R; Perlman A; Rotshild V; Muszkat M; Matok I
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610207
[TBL] [Abstract][Full Text] [Related]
7. Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.
Trac MH; McArthur E; Jandoc R; Dixon SN; Nash DM; Hackam DG; Garg AX
CMAJ; 2016 Apr; 188(7):E120-E129. PubMed ID: 26903359
[TBL] [Abstract][Full Text] [Related]
8. Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.
Zambon A; Polo Friz H; Contiero P; Corrao G
Drug Saf; 2009; 32(2):159-67. PubMed ID: 19236122
[TBL] [Abstract][Full Text] [Related]
9. Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.
Wong AYS; Chan EW; Anand S; Worsley AJ; Wong ICK
Drug Saf; 2017 Aug; 40(8):663-677. PubMed ID: 28397186
[TBL] [Abstract][Full Text] [Related]
10. Clarithromycin use and the risk of mortality and cardiovascular events: A systematic review and meta-analysis.
You CH; Lin CK; Chen PH; Park S; Chen YY; Khan N; Papatheodorou SI; Chen ST
PLoS One; 2019; 14(12):e0226637. PubMed ID: 31881052
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death.
Rao GA; Mann JR; Shoaibi A; Bennett CL; Nahhas G; Sutton SS; Jacob S; Strayer SM
Ann Fam Med; 2014; 12(2):121-7. PubMed ID: 24615307
[TBL] [Abstract][Full Text] [Related]
12. Macrolides use and the risk of sudden cardiac death.
Li X; Wang M; Liu G; Zhou L; Wang Z; Li C
Expert Rev Anti Infect Ther; 2016 Jun; 14(6):535-7. PubMed ID: 27086751
[No Abstract] [Full Text] [Related]
13. Adverse events in people taking macrolide antibiotics versus placebo for any indication.
Hansen MP; Scott AM; McCullough A; Thorning S; Aronson JK; Beller EM; Glasziou PP; Hoffmann TC; Clark J; Del Mar CB
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011825. PubMed ID: 30656650
[TBL] [Abstract][Full Text] [Related]
14. Burden of cardiac arrhythmias in patients with acute myocardial infarction and their impact on hospitalization outcomes: insights from China acute myocardial infarction (CAMI) registry.
Xu X; Wang Z; Yang J; Fan X; Yang Y
BMC Cardiovasc Disord; 2024 Apr; 24(1):218. PubMed ID: 38654151
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
[TBL] [Abstract][Full Text] [Related]
16. Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study.
Kaye JA; Castellsague J; Bui CL; Calingaert B; McQuay LJ; Riera-Guardia N; Saltus CW; Quinlan S; Holick CN; Wahl PM; Suzart K; Rothman KJ; Wallander MA; Perez-Gutthann S
Pharmacotherapy; 2014; 34(4):336-49. PubMed ID: 24865821
[TBL] [Abstract][Full Text] [Related]
17. Association of Patient Enrollment in Medicare Part D With Outcomes After Acute Myocardial Infarction.
Goyal A; de Lemos JA; Peng SA; Thomas L; Amsterdam EA; Hockenberry JM; Peterson ED; Wang TY
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):567-75. PubMed ID: 26508667
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis.
Assimon MM; Pun PH; Wang LC; Al-Khatib SM; Brookhart MA; Weber DJ; Winkelmayer WC; Flythe JE
JAMA Cardiol; 2022 Jan; 7(1):75-83. PubMed ID: 34668928
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolones and the risk of serious arrhythmia: a population-based study.
Lapi F; Wilchesky M; Kezouh A; Benisty JI; Ernst P; Suissa S
Clin Infect Dis; 2012 Dec; 55(11):1457-65. PubMed ID: 22865870
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics for secondary prevention of coronary heart disease.
Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
